Amphastar Pharmaceuticals (AMPH) Treasury Shares (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Treasury Shares of $30.0 million for Q1 2026, up 167.4% year-over-year from $11.2 million in Q1 2025, and down 92.65% quarter-over-quarter from $408.1 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Treasury Shares (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Treasury Shares history runs 13 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 167.4% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 167.4% YoY), while the FY2025 annual figure was $408.1 million, up 377.6% from the prior year.
- Treasury Shares for Q1 2026 stood at $30.0 million, down from $408.1 million in the prior quarter.
- The five-year high for Treasury Shares was -$10.0 million in Q4 2022, with the low at -$17.5 million in Q1 2026.
- The 5-year median for Treasury Shares is -$13.2 million (2024), against an average of -$13.4 million.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares slumped 97.89% in 2023, then jumped 6487.6% in 2024.
- Amphastar Pharmaceuticals' Treasury Shares stood at $39.9 million in 2022, then surged by 45.69% to $58.1 million in 2023, then surged by 46.98% to $85.5 million in 2024, then jumped by 377.6% to $408.1 million in 2025, then tumbled by 92.65% to $30.0 million in 2026.
- Business Quant data shows AMPH's Treasury Shares at $30.0 million in Q1 2026, $408.1 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.11 Bn | 43.15 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.84 Bn | 30.17 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.44 Bn | 19.78 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.06 Bn | 9.89 Bn | - | 19.00 Mn |
| 10 | Amphastar Pharmaceuticals | 942.27 Mn | 652.15 Mn | 93.47 Mn | -19.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.20 Mn |
| Jun 30, 2026 | -19.77 Mn |
| Jun 30, 2026 | -19.77 Mn |
| Jun 30, 2026 | 74.20 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Mar 31, 2026 | -17.50 Mn |
| Mar 31, 2026 | -17.50 Mn |
| Dec 31, 2025 | -16.13 Mn |
| Dec 31, 2025 | -16.13 Mn |
| Dec 31, 2025 | 408.15 Mn |
| Dec 31, 2025 | 408.15 Mn |
| Sep 30, 2025 | 4.85 Mn |
| Sep 30, 2025 | -15.33 Mn |
| Sep 30, 2025 | -15.33 Mn |
| Sep 30, 2025 | 4.85 Mn |
| Jun 30, 2025 | -15.16 Mn |
| Jun 30, 2025 | -15.16 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Jun 30, 2025 | 39.00 Mn |